Baird Financial Group’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,251
| Closed | -$2.59M | – | 1941 |
|
|
2021
Q3 | $2.59M | Buy |
6,251
+6,126
| +4,901% | +$2.53M | 0.01% | 838 |
|
|
2021
Q2 | $38K | Buy |
+125
| New | +$38K | ﹤0.01% | 1732 |
|
|
2018
Q4 | – | Sell |
-2,176
| Closed | -$933K | – | 1373 |
|
|
2018
Q3 | $933K | Buy |
2,176
+17
| +0.8% | +$7.29K | 0.01% | 870 |
|
|
2018
Q2 | $876K | Buy |
2,159
+60
| +3% | +$24.3K | 0.01% | 861 |
|
|
2018
Q1 | $1.15M | Buy |
2,099
+1,309
| +166% | +$714K | 0.01% | 790 |
|
|
2017
Q4 | $477K | Buy |
+790
| New | +$477K | ﹤0.01% | 1029 |
|